Nexalin Technology (NXL) Interest Coverage Ratio (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Interest Coverage Ratio of 62350.06 in Q1 2026, up 310.82% quarter-over-quarter from 15177.15 in Q4 2025, and up 3319.41% on a YoY basis from 1823.41 in Q1 2025.
Nexalin Technology (NXL) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Nexalin Technology's Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 62350.06 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 3319.41% year-over-year to 62350.06; the TTM figure through Mar 2026 stood at 1185.27 (down 45.56% YoY), while the FY2025 annual figure was 1018.31, down 58.07% from the prior year.
- Interest Coverage Ratio was 62350.06 for Q1 2026 at Nexalin Technology, up from 15177.15 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 62350.06 in Q1 2026 to a low of 453.2 in Q3 2023.
- Historically, Interest Coverage Ratio has averaged 6693.99 across 5 years, with a median of 685.39 in 2025.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio slumped 1515.59% in 2023, then soared 12466.72% in 2024.
- A 5-year view of Interest Coverage Ratio shows it stood at 53.32 in 2022, then tumbled by 59.09% to 84.83 in 2023, then surged by 1959.38% to 1577.29 in 2024, then jumped by 862.23% to 15177.15 in 2025, then soared by 310.82% to 62350.06 in 2026.
- The last three Interest Coverage Ratio figures came in at 62350.06 (Q1 2026), 15177.15 (Q4 2025), and 1025.19 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.98 |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | 62,350.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62,350.06 |
| Dec 31, 2025 | 15,177.15 |
| Sep 30, 2025 | 1,025.19 |
| Jun 30, 2025 | 345.60 |
| Mar 31, 2025 | 1,823.41 |
| Dec 31, 2024 | 1,577.29 |
| Sep 30, 2024 | 2,508.52 |
| Jun 30, 2024 | 19,651.83 |
| Mar 31, 2024 | 3,531.95 |
| Dec 31, 2023 | -84.83 |
| Sep 30, 2023 | -453.20 |
| Jun 30, 2023 | -158.91 |
| Mar 31, 2023 | -88.20 |
| Dec 31, 2022 | -53.32 |
| Sep 30, 2022 | -28.05 |
| Mar 31, 2022 | -20.69 |
| Dec 31, 2021 | -31.32 |
| Sep 30, 2021 | -66.07 |